Quarterly report pursuant to Section 13 or 15(d)

Net Loss Per Share of Common Stock - Schedule of Antidilutive Securities Excluded from Computation of Diluted Weighted Average Shares Outstanding (Detail)

v3.21.1
Net Loss Per Share of Common Stock - Schedule of Antidilutive Securities Excluded from Computation of Diluted Weighted Average Shares Outstanding (Detail) - shares
3 Months Ended
Mar. 31, 2021
Mar. 31, 2020
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]    
Potentially antidilutive securities outstanding excluded from the computation of diluted weighted average shares 14,252,787 4,851,784
Employee Stock Options [Member]    
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]    
Potentially antidilutive securities outstanding excluded from the computation of diluted weighted average shares 1,925,197 1,818,588
Warrants [Member]    
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]    
Potentially antidilutive securities outstanding excluded from the computation of diluted weighted average shares 12,327,590 3,033,196